IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q1 2023 Holdings

Filed 2023-05-15 | 11 holdings | $143.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corp(LQDA)COM NEW53635D202$63.9M9,243,62744.6%
Anika Therapeutics Inc(ANIK)COM035255108$20.5M715,29114.3%
Standard Biotools Inc(LAB)COM34385P108$16.7M8,576,79911.7%
Exelixis Inc(EXEL)COM30161Q104$16.5M850,00011.5%
Evolus Inc(EOLS)COM30052C107$12.9M1,523,4849.0%
Adma Biologics Inc(ADMA)COM000899104$5.5M1,662,6133.8%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$3.7M183,0642.6%
Societal Cdmo IncCOM75629F109$1.3M1,077,2680.9%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$1.3M435,2980.9%
Alimera Sciences IncCOM NEW016259202$1.0M478,7770.7%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$99.5K4,3330.1%